Single-dose pharmacokinetics of temocapril and temocapril diacid in subjects with varying degrees of renal impairment

被引：0
|
作者：
B. Sierakowski
K. Püchler
P. U. Witte
K. Renneisen
I. Roots
机构：
[1] Sankyo Europe GmbH,
[2] Immermannstrasse 45,undefined
[3] D-40210 Duesseldorf,undefined
[4] Germany Tel. +49 211 367 88-52; Fax +49 211 362 799,undefined
[5] Imform GmbH,undefined
[6] D-02826 Goerlitz,undefined
[7] Germany,undefined
[8] Institute of Clinical Pharmacology,undefined
[9] University Clinic Charité,undefined
[10] Humboldt University,undefined
[11] D-10098 Berlin,undefined
[12] Germany,undefined
来源：
European Journal of Clinical Pharmacology | 1997年 / 53卷
关键词：
Key words Temocapril; Renal failure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: The aim of this study was to determine the influence of renal impairment on the single-dose pharmacokinetics of temocapril and its pharmacologically active metabolite, temocapril diacid.
引用
收藏
页码：215 / 220
页数：5
相关论文
共 50 条
  • [11] Pharmacokinetics of Tapentadol in Subjects With Varying Degrees of Renal Impairment
    Smit, J. W.
    Kleideiter, E.
    Brett, M.
    Lannie, C.
    Mangold, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1079 - 1079
  • [12] PHARMACOKINETICS OF FAMCICLOVIR IN SUBJECTS WITH VARYING DEGREES OF RENAL IMPAIRMENT
    BOIKE, SC
    PUE, MA
    FREED, MI
    AUDET, PR
    FAIRLESS, A
    ILSON, BE
    ZARIFFA, N
    JORKASKY, DK
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) : 418 - 426
  • [13] Pharmacokinetics of single-dose oral stavudine in subjects with renal impairment and in subjects requiring hemodialysis
    Grasela, DM
    Stoltz, RR
    Barry, M
    Bone, M
    Mangold, B
    O'Grady, P
    Raymond, R
    Haworth, SJ
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) : 2149 - 2153
  • [14] Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency
    Kenneth C. Lasseter
    Ander Sologuren
    Anna La Noce
    Stacy C. Dilzer
    Clinical Drug Investigation, 2013, 33 : 665 - 673
  • [15] Evaluation of the Single-dose Pharmacokinetics of Bilastine in Subjects with Various Degrees of Renal Insufficiency
    Lasseter, Kenneth C.
    Sologuren, Ander
    La Noce, Anna
    Dilzer, Stacy C.
    CLINICAL DRUG INVESTIGATION, 2013, 33 (09) : 665 - 673
  • [16] A phase 1, open-label, single-dose study of the pharmacokinetics of zanubrutinib in subjects with varying degrees of hepatic impairment
    Ou, Ying C.
    Preston, Richard A.
    Marbury, Thomas C.
    Tang, Zhiyu
    Novotny, William
    Tawashi, Manal
    Li, Ta-Kai
    Sahasranaman, Srikumar
    LEUKEMIA & LYMPHOMA, 2020, 61 (06) : 1355 - 1363
  • [17] PHARMACOKINETICS OF A SINGLE INTRAVENOUS DOSE OF TEICOPLANIN IN SUBJECTS WITH VARIOUS DEGREES OF RENAL IMPAIRMENT
    BONATI, M
    TRAINA, GL
    ROSINA, R
    BUNIVA, G
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 : 29 - 37
  • [18] Single-dose pharmacokinetics of nefazodone in healthy young and elderly subjects and in subjects with renal or hepatic impairment
    Barbhaiya, RH
    Shukla, UA
    Greene, DS
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1995, 49 (03) : 221 - 228
  • [19] SINGLE-DOSE PHARMACOKINETICS OF ALP2011 IN SUBJECTS WITH VARIOUS DEGREES OF HEPATIC IMPAIRMENT.
    Michaud, J.
    Fazio, C.
    Boily, S.
    Massicotte, J.
    Sicard, E.
    Lefebvre, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S77 - S77
  • [20] Single dose and steady state pharmacokinetics of temocapril and temocaprilat in young and elderly hypertensive patients
    Püchler, K
    Sierakowski, B
    Roots, I
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 46 (04) : 363 - 367
12345